Bacillus anthracis protective antigen Antibody Blocking Peptide

• Applications: AC
• Concentration: 1 mg/ml

Bacillus anthracis protective antigen Antibody Blocking Peptide Summary

• Specificity: This peptide is specific for NB120-13808 only.
• Protein/Peptide Type: Antibody Blocking Peptide

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NB120-13808. For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -80C. Avoid freeze-thaw cycles.
• Buffer: Peptide dissolved in dH20. Contains no BSA.
• Preservative: No Preservative
• Concentration: 1 mg/ml

Alternate Names for Bacillus anthracis protective antigen Antibody Blocking Peptide

• anthrax PA
• Anthrax toxins translocating protein
• PA 83
• PA
• PA83
• PAG
• Paga
• Protective antigen

Background

Anthrax toxins are composed of three distinct proteins, a protective antigen (PA), a lethal factor (LF) and an edema factor (EF). None of these proteins are toxic by themselves and several studies indicate that the anthrax toxin has the familiar A-B enzymatic binding structure, with PA acting as the binding domain and EF and/or LF acting as the active fragments.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.